Vaccine News and Research

Latest Vaccine News and Research

Tumor cells manipulate unfolded protein response

Researchers at the University of California, San Diego School of Medicine report that tumor cells use stress signals to subvert responding immune cells, exploiting them to actually boost conditions beneficial to cancer growth.

19 Dec 2012

Meeting participants discuss HHS framework for funding H5N1 avian influenza research

CIDRAP News reports on a two-day meeting at the National Institutes of Health during which "researchers, biosecurity experts, and others" discussed the "crafting of a framework for funding H5N1 avian influenza gain-of-function studies." The meeting "is the latest chapter in an intense scientific controversy that was triggered by the publication of two recent studies involving lab-engineered H5N1 strains that showed signs of being transmissible in mammals," according to the news service.

19 Dec 2012

Blogs discuss conference on neglected diseases

Several blogs recently reported on issues discussed last week during a conference sponsored by Medecins Sans Frontieres (MSF), the Drugs for Neglected Diseases initiative (DNDi), and the Mount Sinai School of Medicine in New York, titled "Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations."

18 Dec 2012

Global travel, climate warming could create right conditions for chikungunya outbreaks in the U.S.

Global travel and climate warming could be creating the right conditions for outbreaks of a new virus in this country, according to a new Cornell University computer model.

18 Dec 2012

Experts warn banning thimerosal from use in vaccines would harm immunization campaigns in developing world

"A group of prominent doctors and public health experts warns in articles to be published Monday in the journal Pediatrics that banning thimerosal, a mercury compound used as a preservative in vaccines, would devastate public health efforts in developing countries," the New York Times reports.

17 Dec 2012

GSK receives FDA approval for FLUARIX QUADRIVALENT to treat seasonal flu

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved FLUARIX QUADRIVALENT (Influenza Virus Vaccine) for the immunisation of children (three years and older) and adults to help prevent disease caused by seasonal influenza (flu) virus subtypes A and type B contained in the vaccine.

17 Dec 2012

Maryland researchers launch groundbreaking study into spread of drug-resistant malaria in Burma

University of Maryland School of Medicine researchers have launched groundbreaking research into the spread of potentially deadly drug-resistant malaria in the developing Southeast Asian nation of Myanmar, also known as Burma.

17 Dec 2012

First Edition: December 17, 2012

Today's headlines include weekend updates regarding the fiscal cliff negotiations as well as news regarding states' decisions on health exchanges.

17 Dec 2012

Increased life expectancy not benefitting everybody equally: U of T

Global lifespans have risen dramatically in the past 40 years, but the increased life expectancy is not benefitting everybody equally, say University of Toronto researchers. In particular, adult males from low- and middle-income countries are losing ground.

17 Dec 2012

Conference addresses issues of innovation for neglected diseases

Medecins Sans Frontieres, the Drugs for Neglected Diseases initiative, and the Mount Sinai School of Medicine this week are hosting a conference in New York, titled "Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations," the Philadelphia Inquirer reports.

15 Dec 2012

Efforts to prevent, treat cervical cancer increasing in Africa

The Guardian's "Poverty Matters Blog" examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where "cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late."

15 Dec 2012

Scientists discover how Yersinia pestis avoids setting off immune system's early infection-alarm

The plague-causing bacteria Yersinia pestis evades detection and establishes a stronghold without setting off the body's early alarms.

14 Dec 2012

CEL-SCI net loss decreases to $17.6 million for fiscal year 2012

CEL-SCI Corporation reported financial results today for the fiscal year ended September 30, 2012.

14 Dec 2012

Malaria vaccine trial: an interview with Professor Sir Brian Greenwood

Malaria is an infection caused by a parasite called plasmodium, which is transmitted from person to person by females of some species of mosquito. It is primarily a disease of tropical countries.

14 Dec 2012

Continue support of GAVI Alliance and childhood disease prevention

"Last week a global health event took place in Dar Es Salaam, Tanzania, to foster greater political will and explore ways to accelerate results, innovation, sustainability, and equity in the field of immunization," Baroness Hollins, emeritus professor of psychiatry of disability at St George's University of London, writes in the BMJ Group Blog about the GAVI Partners Forum.

14 Dec 2012

NovaDigm announces data from NDV-3 vaccine Phase 1 study on Candida and Staph infections

NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced the publication of data from its first-in-human Phase 1 study of its NDV-3 vaccine program in the journal Vaccine.

13 Dec 2012

Fatal imbalance between global disease burden and drug development

Despite important progress in research and development (R&D) for global health over the past decade, only a small fraction of new medicines developed between 2000 and 2011 were for the treatment of neglected diseases, highlighting the 'fatal imbalance' between global disease burden and drug development for some of the world most devastating illnesses, said Doctors Without Borders/M-decins Sans Fronti-res (MSF) and the Drugs for Neglected Diseases initiative (DNDi), in an analysis to be presented today at an international conference aimed at spurring medical innovations for these diseases.

13 Dec 2012

Patients with multiple sclerosis have low levels of Egr2/3 protein in T lymphocytes

Researchers from Queen Mary, University of London have discovered that two proteins which are believed to play a key role in controlling the body's immune response are found in lower levels in T lymphocytes from patients with multiple sclerosis (MS).

13 Dec 2012

Study investigates different approaches to eradicate mosquito-borne diseases

A special issue of Pathogens and Global Health, published by Maney Publishing, investigates different approaches to eradicate mosquito-borne diseases. Mosquitoes can transmit a number of pathogenic diseases including dengue fever, yellow fever, and malaria.

13 Dec 2012

Roundup: Health centers moving into contaminated tracts; Mass. budget cuts worry health advocates

The community health center rising on a derelict corner here in West Philadelphia never would have broken ground if not for the asbestos inside the building that was demolished to make way for it. Because of the contamination, Spectrum Health Services received a $2 million federal cleanup grant, the first piece of a $14 million construction financing puzzle.

13 Dec 2012

Vaccine News and Research

Latest Vaccine News and Research

Tumor cells manipulate unfolded protein response

Meeting participants discuss HHS framework for funding H5N1 avian influenza research

Blogs discuss conference on neglected diseases

Global travel, climate warming could create right conditions for chikungunya outbreaks in the U.S.

Experts warn banning thimerosal from use in vaccines would harm immunization campaigns in developing world

GSK receives FDA approval for FLUARIX QUADRIVALENT to treat seasonal flu

Maryland researchers launch groundbreaking study into spread of drug-resistant malaria in Burma

First Edition: December 17, 2012

Increased life expectancy not benefitting everybody equally: U of T

Conference addresses issues of innovation for neglected diseases

Efforts to prevent, treat cervical cancer increasing in Africa

Scientists discover how Yersinia pestis avoids setting off immune system's early infection-alarm

CEL-SCI net loss decreases to $17.6 million for fiscal year 2012

Malaria vaccine trial: an interview with Professor Sir Brian Greenwood

Continue support of GAVI Alliance and childhood disease prevention

NovaDigm announces data from NDV-3 vaccine Phase 1 study on Candida and Staph infections

Fatal imbalance between global disease burden and drug development

Patients with multiple sclerosis have low levels of Egr2/3 protein in T lymphocytes

Study investigates different approaches to eradicate mosquito-borne diseases

Roundup: Health centers moving into contaminated tracts; Mass. budget cuts worry health advocates

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in